The Recombinase FimX: Role in type 1 pili regulation and E. coli-induced cystitis

重组酶 FimX:在 1 型菌毛调节和大肠杆菌诱导的膀胱炎中的作用

基本信息

  • 批准号:
    7447904
  • 负责人:
  • 金额:
    $ 11.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-10 至 2010-11-09
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 1 pili, the preeminent virulence determinant in Escherichia coli-associated cystitis, promote binding to the bladder surface and facilitate the colonization and invasion of the epithelium. In their intracellular residence, E. coli amass into communal formations with biofilm-like properties termed intracellular bacterial communities (IBC) and then disperse and flux from the infected cell into the lumen of the bladder. Upon fluxing, type 1 pili may again mediate adherence to naive epithelial cells, reinitiating invasion and IBC formation. Because of the central role of type 1 pili in uropathogenesis, understanding the regulation of these fibers is essential for a complete molecular description of the infection and ultimately to identify novel targets for therapeutics. Type 1 pili are regulated by two recombinases, FimB and FimE, that together dynamically modulate the expression of the fibers through phase variation whereby the promoter region is inverted into ON and OFF positions. Preliminary studies have identified FimX, a third site-specific recombinase that, despite the absence of FimB and FimE, produces phase variation and the expression of type 1 pili and supports full virulence. Ablation of FimX and the other two recombinases renders the organism avirulent. We hypothesize that FimX, as regulator of type 1 pili expression, is a central virulence determinant in E. coli urinary tract infections. In Aim 1 of this proposal, we will use a combination of molecular epidemiology, genetics, and animal modeling to characterize the prevalence of fimX and study the in vivo role of FimX as a regulator of type 1 pili in E. coli cystitis. In Aim 2, through the use of genetics and biochemistry, we will study the structure-function relationships of FimX and its target DNA sequences. Given the central role of the Fim recombinases in regulating type 1 pili expression, understanding their functions and constraints may yield novel points for treatment and prevention in urinary tract infections.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick C. Seed其他文献

Role of the upper airway microbiota in respiratory virus and bacterial pathobiont dynamics in the first year of life
上呼吸道微生物群在生命第一年中呼吸道病毒和细菌病原体动态中的作用
  • DOI:
    10.1038/s41467-025-60552-4
  • 发表时间:
    2025-06-04
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Matthew S. Kelly;Pixu Shi;Sifelane C. Boiditswe;Emily Qin;Andrew P. Steenhoff;Tiny Mazhani;Mohamed Z. Patel;Coleen K. Cunningham;John F. Rawls;Kathy Luinstra;Jodi Gilchrist;Julia Maciejewski;Jillian H. Hurst;Patrick C. Seed;David Bulir;Marek Smieja
  • 通讯作者:
    Marek Smieja
Blueprinting the regulatory response of <em>Escherichia coli</em> to the urinary tract
  • DOI:
    10.1016/j.tim.2005.03.014
  • 发表时间:
    2005-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Patrick C. Seed;Scott J. Hultgren
  • 通讯作者:
    Scott J. Hultgren

Patrick C. Seed的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick C. Seed', 18)}}的其他基金

MICROBIAL SUCCESSION AND ADAPTIVE IMMUNE RESPONSES IN THE PREMATURE INFANT
早产儿的微生物演替和适应性免疫反应
  • 批准号:
    8605301
  • 财政年份:
    2014
  • 资助金额:
    $ 11.52万
  • 项目类别:
Novel modulation of E.coli virulence through capsule development and sialic acid
通过胶囊发育和唾液酸对大肠杆菌毒力的新调节
  • 批准号:
    8108430
  • 财政年份:
    2010
  • 资助金额:
    $ 11.52万
  • 项目类别:
Screening For Inhibitors of Bacterial Capsule Biogenesis
细菌荚膜生物发生抑制剂的筛选
  • 批准号:
    8088236
  • 财政年份:
    2010
  • 资助金额:
    $ 11.52万
  • 项目类别:
Screening For Inhibitors of Bacterial Capsule Biogenesis
细菌荚膜生物发生抑制剂的筛选
  • 批准号:
    7923438
  • 财政年份:
    2010
  • 资助金额:
    $ 11.52万
  • 项目类别:
The Recombinase FimX: Role in type 1 pili regulation and E. coli-induced cystitis
重组酶 FimX:在 1 型菌毛调节和大肠杆菌诱导的膀胱炎中的作用
  • 批准号:
    7985158
  • 财政年份:
    2009
  • 资助金额:
    $ 11.52万
  • 项目类别:
The Recombinase FimX: Role in type 1 pili regulation and E. coli-induced cystitis
重组酶 FimX:在 1 型菌毛调节和大肠杆菌诱导的膀胱炎中的作用
  • 批准号:
    7257254
  • 财政年份:
    2006
  • 资助金额:
    $ 11.52万
  • 项目类别:
Recombinase FimX: Role in type 1 pili regulation and
重组酶 FimX:在 1 型菌毛调节和
  • 批准号:
    7076649
  • 财政年份:
    2006
  • 资助金额:
    $ 11.52万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 11.52万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 11.52万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 11.52万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 11.52万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 11.52万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 11.52万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 11.52万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 11.52万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 11.52万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 11.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了